Veterinärmedizinische Universität Wien Forschungsinformationssystem VetDoc

Grafischer Link zur Startseite der Vetmeduni Vienna

Restitutti Flavia,

** = Publikationen gelistet in SCI/SSCI/Pubmed



** Einwaller, J; Painer, J; Raekallio, M; Gasch, K; Restitutti, F; Auer, U; Stalder, GL (2020): Cardiovascular effects of intravenous vatinoxan (MK-467) in medetomidine-tiletamine-zolazepam anaesthetised red deer (Cervus elaphus). Vet Anaesth Analg. 2020; 47(4):518-527


** Turunen, H; Raekallio, MR; Honkavaara, JM; Restitutti, F; Kallio-Kujala, IJ; Adam, M; Nevanperä, K; Scheinin, M; Männikkö, SK; Hautajärvi, HJ; Larenza Menzies, P; Vainio, OM (2019): Cardiovascular and sedation reversal effects of intramuscular administration of atipamezole in dogs treated with medetomidine hydrochloride with or without the peripheral alpha(2)-adrenoceptor antagonist vatinoxan hydrochloride. Am J Vet Res 80(10): 912-922.

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Einwaller, J; Painer, J; Gasch, K; Restitutti, F; Raekallio, M; Auer, U; Stalder, G (2019): Effects Of The Peripheral α2-Adrenoceptor Antagonist Vatinoxan On Medetomidine-Induced Bradycardia And Hypertension In Red Deer (Cervus Elaphus). 49-50.-Joint Leibniz-IZW/EAZWV/ECZM Zoo and Wildlife Health Conference 2019; Jun 12-15, 2019; Kolmarden, Sweden.



** Restitutti, F; Kaartinen, MJ; Raekallio, MR; Wejberg, O; Mikkola, E; del Castillo, JRE; Scheinin, M; Vainio, OM (2017): Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha(2)-antagonist MK-467 in dogs. Vet Anaesth Analg. 2017; 44(3): 417-426.

Publizierter (zitierfähiger) Beitrag für wissenschaftliche Veranstaltung in Proceedings (A2)

Turunen, H; Raekallio, M; Adam, M; Helin, H; Nevanperä, K; Kallio-Kujala, I; Honkavaara, J; Restitutti, F; Larenza, MP (2017): The effects of MK-467, a peripheral alpha2-adrenergic receptor atagonist, on the plasma drug concentrations and sedation in dogs receiving atipamezole to reverse medetomidine-induced sedation. -AVA Autumn Meeting; NOV 9-12,2017; Berlin, Germany.



** Grobelna, AP; Honkavaara, J; Restitutti, F; Huuskonen, V; Sakka, SG; Spillmann, T (2016): Evaluation of a transcutaneous method to assess canine liver function by indocyanine green plasma disappearance rate in healthy adult Beagle dogs. Vet J. 2016; 209:169-173


** Salla, K; Bennett, RC; Restitutti, F; Junnila, J; Raekallio, M; Vainio, O (2014): A comparison in dogs of medetomidine, with or without MK-467, and the combination acepromazine-butorphanol as premedication prior to anaesthesia induced by propofol and maintained with isoflurane. Vet Anaesth Analg. 2014; 41(2):163-173

** Salla, K; Restitutti, F; Vainionpää, M; Junnila, J; Honkavaara, J; Kuusela, E; Raekallio, M; Vainio, O (2014): The cardiopulmonary effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in dogs sedated with a combination of medetomidine and butorphanol. Vet Anaesth Analg. 2014; 41(6):567-574


** Restitutti, F; Laitinen, MR; Raekallio, MR; Vainionpää, M; O"Brien, RT; Kuusela, E; Vainio, OM (2013): Effect of MK-467 on organ blood flow parameters detected by contrast-enhanced ultrasound in dogs treated with dexmedetomidine. Vet Anaesth Analg. 2013; 40(6):E48-E56

** Vainionpää, M; Salla, K; Restitutti, F; Raekallio, M; Junnila, J; Snellman, M; Vainio, O (2013): Thermographic imaging of superficial temperature in dogs sedated with medetomidine and butorphanol with and without MK-467 (L-659"066). Vet Anaesth Analg. 2013; 40(2):142-148


** Campagnol, D; Teixeira-Neto, FJ; Monteiro, ER; Restitutti, F; Minto, BW (2012): Effect of intraperitoneal or incisional bupivacaine on pain and the analgesic requirement after ovariohysterectomy in dogs. Vet Anaesth Analg. 2012; 39(4):426-430

** Honkavaara, J; Restitutti, F; Raekallio, M; Salla, K; Kuusela, E; Ranta-Panula, V; Rinne, V; Vainio, O; Scheinin, M (2012): Influence of MK-467, a peripherally acting α2-adrenoceptor antagonist on the disposition of intravenous dexmedetomidine in dogs. Drug Metab Dispos. 2012; 40(3):445-449

** Restitutti, F; Raekallio, M; Vainionpää, M; Kuusela, E; Vainio, O (2012): Plasma glucose, insulin, free fatty acids, lactate and cortisol concentrations in dexmedetomidine-sedated dogs with or without MK-467: a peripheral α-2 adrenoceptor antagonist. Vet J. 2012; 193(2):481-485


** Honkavaara, JM; Restitutti, F; Raekallio, MR; Kuusela, EK; Vainio, OM (2011): The effects of increasing doses of MK-467, a peripheral alpha(2)-adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs. J Vet Pharmacol Ther. 2011; 34(4):332-337

** Restitutti, F; Honkavaara, JM; Raekallio, MR; Kuusela, EK; Vainio, OM (2011): Effects of different doses of L-659"066 on the bispectral index and clinical sedation in dogs treated with dexmedetomidine. Vet Anaesth Analg. 2011; 38(5):415-422


** Credie, RG; Teixeira Neto, FJ; Ferreira, TH; Aguiar, AJ; Restitutti, FC; Corrente, JE (2010): Effects of methadone on the minimum alveolar concentration of isoflurane in dogs. Vet Anaesth Analg. 2010; 37(3):240-249

© Veterinärmedizinische Universität Wien Hilfe und Downloads